Arthur F. Ryan, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 100 shares at $701.76 ($71K) on 2026-05-01, disclosed to the SEC on 2026-05-04.
Scheduled sale ($71k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $701.76 | 5 | $4K | 5.0% |
| 2 | $702.46 | 15 | $11K | 14.9% |
| 3 | $703.46 | 24 | $17K | 23.9% |
| 4 | $704.28 | 15 | $11K | 15.0% |
| 5 | $705.56 | 14 | $10K | 14.0% |
| 6 | $706.74 | 7 |
| $5K |
| 7.0% |
| 7 | $707.40 | 4 | $3K | 4.0% |
| 8 | $709.45 | 6 | $4K | 6.0% |
| 9 | $710.87 | 2 | $1K | 2.0% |
| 10 | $711.49 | 5 | $4K | 5.0% |
| 11 | $712.09 | 1 | $712 | 1.0% |
| 12 | $714.13 | 2 | $1K | 2.0% |
| Total | $705.24 avg | 100 | $71K | 100% |
| Filing → |
| REGN | SELL | 2026-03-03 | $79K | — | Filing → |
| REGN | SELL | 2026-02-11 | $78K | — | Filing → |
| REGN | SELL | 2024-10-03 | $105K | — | Filing → |